BNT162b2 vaccine induced variant-specific immunity, safety and risk of Omicron breakthrough infection in children aged 5 to 11 years: a cohort study

There is little information on BNT162b2 vaccine-induced variant-specific immunogenicity, safety data and dynamics of breakthrough infections in pediatric populations. We addressed these questions using a prospective two dose BNT162b2 (10 mcg) vaccination cohort study of healthy children 5–11 years i...

Descripción completa

Detalles Bibliográficos
Autores principales: Yung, Chee Fu, Le Bert, Nina, Kam, Kai Qian, Saffari, Seyed Ehsan, Tan, Chee Wah, Mah, Yun Yan, Zhang, Jinyan, Yeoh, Aileen Ying-Yan, Zhu, Feng, Hariharaputran, Smrithi, Chong, Chia Yin, Bertoletti, Antonio, Wang, Linfa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575958/
https://www.ncbi.nlm.nih.gov/pubmed/37833554
http://dx.doi.org/10.1038/s41598-023-44565-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10575958/
https://www.ncbi.nlm.nih.gov/pubmed/37833554
http://dx.doi.org/10.1038/s41598-023-44565-x

Ejemplares similares